An Organ-sparing Treatment Using Combined Intra-arterial Chemotherapy and Radiotherapy for Muscle-invading Bladder Carcinoma-Reference-Cited by-同舟云学术

An Organ-sparing Treatment Using Combined Intra-arterial Chemotherapy and Radiotherapy for Muscle-invading Bladder Carcinoma

Published:2002-01-01 Issue:5 Volume:36 Page:339-343
ISSN:0036-5599
Container-title:Scandinavian Journal of Urology and Nephrology
language:en
Short-container-title:Scandinavian Journal of Urology and Nephrology

Author:

Tsukamoto Sadamu¹,Ishikawa Satoru²,Tsutsumi Masakazu³,Nakajima Kotaro⁴,Sugahara Shinji⁵

Affiliation:

1. Department of Urology, Hitachi, Ltd., Hitachi General Hospital, Ibaraki, Japan and Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan

2. Department of Urology, Hitachi, Ltd., Hitachi General Hospital, Ibaraki, Japan

3. Department of Urology, Hitachi, Ltd., Hitachi General Hospital, Ibaraki

4. Department of Radiology, Hitachi, Ltd., Hitachi General Hospital, Ibaraki, Japan

5. Department of Radiology, Hitachi, Ltd., Hitachi General Hospital and Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan

Publisher

Informa UK Limited

Subject

Urology,Nephrology

Link

https://www.tandfonline.com/doi/pdf/10.1080/003655902320783836

Reference18 articles.

1. Raghavan D, Shipley WU, Garnick MB, Russell PJ, Richie JP. Biology and management of bladder cancer. N Engl J Med 1990; 322: 1129-38.

2. Skinner DG, Stein JP, Lieskovsky G, Skinner EC, Boyd SD, Figueroa A, et al. 25-year experience in the management of invasive bladder cancer by radical cystectomy. Eur Urol 1998; 33 (Suppl 4): 25-6.

3. Sternberg CN, Yagoda A, Scher HI, Watson RC, Geller N, Herr HW, et al. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer 1989; 64: 2448-58.

4. Scher H, Herr H, Sternberg C, Fair W, Bosl G, Morse M, et al. Neo-adjuvant chemotherapy for invasive bladder cancer: experience with the M-VAC regimen. Br J Urol 1989; 64: 250-6.

5. Shipley WU, Winter KA, Kaufman DS, Lee WR, Heney NM, Tester WR, et al. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder canceltreated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol 1998; 16: 3576-83.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Efficacy of Intra-Arterial Plus Intravesical Chemotherapy Versus Intravesical Chemotherapy Alone After Bladder-Sparing Surgery in High-Risk Bladder Cancer: A Systematic Review and Meta-Analysis of Comparative Study;Frontiers in Oncology;2021-05-27

2. Organ preservation for muscle-invasive bladder cancer by preoperative intra-arterial chemotherapy and transurethral resection;Medical Oncology;2014-03-14

3. Analysis of Intravesical Recurrence After Bladder-preserving Therapy for Muscle-invasive Bladder Cancer;Japanese Journal of Clinical Oncology;2012-07-10

4. Intra-Arterial Chemotherapy is Reliable in Preventing High-Risk Superficial Bladder Cancer from Recurrence and Progression;Journal of Chemotherapy;2009-12

5. Intra-Arterial Chemotherapy with Gemcitabine and Cisplatin for Patients with Recurrence of Transitional Cell Carcinoma Confined to the Pelvis;Journal of Chemotherapy;2009-02